Top Twenty Shareholders(Register Extract 8October2009)
Number of Shares
Percentage
Citicorp Nominees Pty Limited
14,767,027
2.243
HSBC Custody Nominees (Australia) Limited
9,037,023
1.373
Comsec Nominees Pty Limited
6,392,595
0.971
Tevlo Pty Ltd
6,225,450
0.946
National Nominees Limited
5,960,269
0.905
Forty Traders Limited
5,756,092
0.874
David John Hanks
5,300,500
0.805
ANZ Nominees Limited
4,983,732
0.757
St. Mellions Inc
4,050,000
0.615
John Daniel Powell
4,000,500
0.608
Douglas Michael Grant & Sharon Leigh Grant
4,000,000
0.608
Manotel Pty Ltd
4,000,000
0.608
Spinite Pty Ltd
3,800,000
0.577
William Douglas Goodfellow
3,281,000
0.498
Sarah Lambeth
3,244,840
0.493
Robert Albert Boas
3,004,130
0.456
Nefco Nominees Pty Ltd
3,000,000
0.456
Wayne Ronald Algie & Kyoko Algie
3,000,000
0.456
BT Portfolio Services Limited
3,000,000
0.456
Net Nominees Limited
- Forums
- ASX - By Stock
- we are getting closer
Top Twenty Shareholders(Register Extract 8October2009)Number of...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.66M |
Open | High | Low | Value | Volume |
50.5¢ | 50.5¢ | 50.5¢ | $14.48K | 28.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5356 | 50.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.0¢ | 59999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30878 | 0.500 |
1 | 30000 | 0.495 |
2 | 28930 | 0.480 |
2 | 70000 | 0.475 |
2 | 78150 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.525 | 69690 | 1 |
0.530 | 30000 | 1 |
0.535 | 30000 | 1 |
0.540 | 52471 | 2 |
0.550 | 82295 | 3 |
Last trade - 15.44pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
FAR (ASX) Chart |